Feasibility studies on biowaiver extension of In vivo bioequivalence of class III drugs based on the biopharmaceutics classification system

dc.contributor.advisorSompol Prakongpan
dc.contributor.advisorDressman Jennifer B.
dc.contributor.advisorAmidon, Gordon L.
dc.contributor.authorEkarat Jantratid
dc.date.accessioned2023-08-25T06:18:53Z
dc.date.available2023-08-25T06:18:53Z
dc.date.copyright2005
dc.date.created2005
dc.date.issued2023
dc.format.extentxxv, 234 leaves : ill.
dc.format.mimetypeapplication/pdf
dc.identifier.citationThesis (Ph.D. (Pharmaceutics))--Mahidol University, 2005
dc.identifier.isbn9740465706
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/88700
dc.language.isoeng
dc.publisherMahidol University. Mahidol University Library and Knowledge Center
dc.rights.holderMahidol University
dc.subjectBiopharmaceutics -- classification
dc.subjectCimetidine
dc.subjectFeasibility Studies
dc.subjectTherapeutic Equivalency
dc.titleFeasibility studies on biowaiver extension of In vivo bioequivalence of class III drugs based on the biopharmaceutics classification system
dc.title.alternativeการศึกษาความเป็นไปได้ในการขอยกเว้นการทดสอบชีวสมมูลของยากลุ่ม 3 ตามคุณสมบัติด้านชีวเภสัชกรรม
dcterms.accessRightsrestricted access
mu.link.internalLinkhttp://mulinet11.li.mahidol.ac.th/e-thesis/4238554.pdf
thesis.degree.departmentFaculty of Pharmacy
thesis.degree.disciplinePharmaceutics
thesis.degree.grantorMahidol University
thesis.degree.levelDoctoral Degree
thesis.degree.nameDoctor of Philosophy

Files

Collections